Product Images Adalimumab-adbm

View Photos of Packaging, Labels & Appearance

Figure 1 - adalimumabqt 01
Figure 2 - adalimumabqt 02
Figure 3 - Study UV I - adalimumabqt 03
Figure 3 - Study UV II - adalimumabqt 04
Image - adalimumabqt 05
Step 1 - adalimumabqt 06
Step 2 - adalimumabqt 07
Step 3 - adalimumabqt 08
Step 4 - adalimumabqt 09
Step 5 - adalimumabqt 10
Step 6 - adalimumabqt 11
Step 7 - adalimumabqt 12
Step 8 - adalimumabqt 13
Step 9 - adalimumabqt 14
Step 10 - adalimumabqt 15
Step 10 - adalimumabqt 16
Step 11 - adalimumabqt 17
Image - adalimumabqt 18
Step 1 - adalimumabqt 19
Step 2 - adalimumabqt 20
Step 3 - adalimumabqt 21
Step 4 - adalimumabqt 22
Step 5 - adalimumabqt 23
Step 6 - adalimumabqt 24
Step 7 - adalimumabqt 25
Step 8 - adalimumabqt 26
Step 9 - adalimumabqt 27
Step 10 - adalimumabqt 28
Step 10 - adalimumabqt 29
Step 11 - adalimumabqt 30
PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-148-22 - adalimumabqt 31
PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-144-22 - adalimumabqt 32
PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-146-22 - adalimumabqt 33
PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-150-22 - adalimumabqt 34

Product Label Images

The following 34 images provide visual information about the product associated with Adalimumab-adbm NDC 82009-150 by Quallent Pharmaceuticals Health Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - adalimumabqt 01

This text provides information about the percentage of patients who are ACR 20 responders when treated with 40 mg every other week compared to those receiving a placebo.*

Figure 2 - adalimumabqt 02

Figure 3 - Study UV I - adalimumabqt 03

Figure 3 - Study UV II - adalimumabqt 04

Not available.*

Image - adalimumabqt 05

Step 1 - adalimumabqt 06

Step 2 - adalimumabqt 07

Step 3 - adalimumabqt 08

Step 4 - adalimumabqt 09

This text contains information about injection sites on the abdomen and thighs, helping with proper administration of injections.*

Step 5 - adalimumabqt 10

Step 6 - adalimumabqt 11

Step 7 - adalimumabqt 12

This is a description instructing to squeeze around the injection site.*

Step 8 - adalimumabqt 13

Step 9 - adalimumabqt 14

This text provides instructions for administering an injection. It guides the reader to press the injection button and hold the pen against the skin while slowly counting to 10.*

Step 10 - adalimumabqt 15

Step 10 - adalimumabqt 16

Step 11 - adalimumabqt 17

Image - adalimumabqt 18

Step 1 - adalimumabqt 19

Step 2 - adalimumabqt 20

Step 3 - adalimumabqt 21

Step 4 - adalimumabqt 22

Step 5 - adalimumabqt 23

Step 6 - adalimumabqt 24

Step 7 - adalimumabqt 25

This text instructs the reader to gently press around the injection site and maintain pressure. This technique may help reduce discomfort and promote proper absorption of the injected substance.*

Step 8 - adalimumabqt 26

Step 9 - adalimumabqt 27

Step 10 - adalimumabqt 28

This text appears to be instructions related to handling a needle. It suggests removing the needle and positioning it at a 45-degree angle.*

Step 10 - adalimumabqt 29

Step 11 - adalimumabqt 30

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-148-22 - adalimumabqt 31

This text appears to be a label or instructions for a medical product, likely related to a medication called Adalimumab-adbm PEN. It contains information about dosage, expiration date, and proper usage guidelines for subcutaneous administration. The product seems to come in single-dose prefilled pens and contains adalimumab. It is important to note that specific details about the medication's administration and storage are also mentioned.*

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-144-22 - adalimumabqt 32

This text refers to the instructions and details of a medication called Adalimumab-adbm PEN Injection, which is intended for subcutaneous use. The medication comes in the form of two single-dose prefilled pens, each containing 40 mg of the solution. It is essential not to use this medication beyond the expiration date mentioned.*

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-146-22 - adalimumabqt 33

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 82009-150-22 - adalimumabqt 34

This is a description of a medication called Adalimumab-adbm, which is an injection containing 40 mg/0.8 mL for subcutaneous use. The medication comes in 2 single-dose prefilled syringes and should not be used beyond the expiration date. It is important for each patient to receive the enclosed medication guide. The packaging includes natural rubber and dry syringes. The text provides detailed instructions and numbers related to dosage and administration.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents